Compositions And Methods For Treating Chronic Inflammation And Inflammatory Diseases
The present specification discloses pharmaceutical compositions, methods of preparing such pharmaceutical compositions, and methods and uses of treating a chronic inflammation and/or an inflammatory disease in an individual using such pharmaceutical compositions.
Claim CLM-00001. 1. A pharmaceutical composition comprising:
a) a therapeutically effective amount of an ibuprofen; b) less than about 20% by weight of the composition of a pharmaceutically-acceptable liquid polyethylene glycol (PEG) polymer; and c) at least 50% by weight of the composition of pharmaceutically-acceptable glycerolipids comprising monoglycerides, diglycerides, and triglycerides; wherein the pharmaceutical composition is formulated to have a melting point temperature of about 25° C. or higher.
